Yesterday, global intravascular robotics leader Hansen Medical announced that its Magellan Robotic System was utilized in two successful live endovascular aortic aneurysm repair (EVAR) cases. Both cases were performed by Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami) Founder and Medical Director Dr. Barry Katzen, who is also a course director at ISET.
ISET is a prominent meeting for interventional radiologists, cardiologists, and endovascular surgeons. The live cases, such as those performed by Dr. Katzen as part of the TCT conference in October 2012, help demonstrate the real-world medical utility of Hansen Medical’s robotic system and its ability to enhance endovascular procedures. Today’s cases demonstrated that robotic catheters can play a valuable role in vascular procedures, and they also indicate the technology’s potential in future clinical applications.
The Magellan Robotic System is based on the flexible robotic technology used in Hansen Medical’s Sensei-X Robotic Catheter System, which is currently being sold in the United States and Europe and has been used in almost 10,000 patients. The Magellan system, however, includes various key enhancements. The Magellan system provides solid catheter stability for placement of therapeutic devices and has been designed to enable predictable procedure times and increased case throughput. The system also allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires. The Magellan system has been designed to allow for sufficient extension inside the body to access hard-to-reach peripheral anatomy, and it also preserves the open architecture featured in the Sensai System, allowing for the subsequent use of many 6F therapeutic devices currently on the market. The Magellan system is also designed to potentially reduce exposure to radiation as well as fatigue for physicians through use of a remote physician workstation.
Based in Mountain View, Calif., Hansen Medical is the world leader in intravascular robotics, developing products and technology designed to enable the accurate positioning, manipulation, and control of catheters and catheter-based technologies. The company’s Magellan Robotic System, Magellan Robotic Catheter, and related accessories – intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices – have undergone both CE marking and 510(k) clearance and are commercially available in the European Union and the U.S.
In the European Union, the company’s Sensei-X Robotic Catheter System and Artisan Control Catheter are cleared for use during electrophysiology (EP) procedures, such as guiding catheters in the treatment of atrial fibrillation (AF), and the Lynx Robotic Ablation Catheter is cleared for the treatment of AF. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3-D surface map and patient electrocardiogram data. In the United States, the company’s Sensei X Robotic Catheter System and Artisan Control Catheter were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in EP procedures.
For more information, visit www.hansenmedical.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
